ACCUSTEM SCIENCES, INC. Share-based Payment Arrangement, Expense
ACCUSTEM SCIENCES, INC. (ACUT) reported Share-based Payment Arrangement, Expense of $0 for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2025-11-12
- ACCUSTEM SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $0.00.
- ACCUSTEM SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $0.00.
- ACCUSTEM SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- ACCUSTEM SCIENCES, INC. share-based payment arrangement, expense for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- ACCUSTEM SCIENCES, INC. share-based payment arrangement, expense for fiscal 2023 was $76.63K, a 42.76% decline from fiscal 2022.
- ACCUSTEM SCIENCES, INC. share-based payment arrangement, expense for fiscal 2022 was $133.89K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-12 | $118.85K 10-Q · filed 2024-11-18 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $50.95K 10-Q · filed 2024-11-18 | $36.07K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $13.93K 10-Q · filed 2024-09-16 | $32.10K 10-Q · filed 2024-09-16 | $36.07K derived: sum of 3 quarters · filed 2025-08-14 | $55.97K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $18.17K 10-Q · filed 2024-05-20 | $36.07K derived: sum of 2 quarters · filed 2024-05-20 | $55.97K derived: sum of 3 quarters · filed 2024-11-18 | $68.59K derived: sum of 4 quarters · filed 2024-11-18 | |
| 2023-12-31 | $17.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $37.80K derived: sum of 2 quarters · filed 2024-11-18 | $50.42K derived: sum of 3 quarters · filed 2024-11-18 | $76.63K 10-K · filed 2024-03-22 | |
| 2023-09-30 | $19.90K 10-Q · filed 2024-11-18 | $32.53K derived: sum of 2 quarters · filed 2024-11-18 | $58.73K 10-Q · filed 2024-11-18 | ||
| 2023-06-30 | $12.63K 10-Q · filed 2024-09-16 | $38.84K 10-Q · filed 2024-09-16 | |||
| 2023-03-31 | $26.21K 10-Q · filed 2024-05-20 | ||||
| 2022-12-31 | $133.89K 10-K · filed 2024-03-22 |